Low molecular weight heparin for the prevention of deep venous thrombosis: a suitable monitoring in elderly patients?
{{output}}
Monitoring of anti-Xa activity (aXa) levels is not routinely required in patients receiving enoxaparine at prophylactic dosages, since aXa is supposed to stay below the manufacturer's recommended range in patients treated for venous thrombosis (0.5-1 IU/ml). I... ...
